Keywords
Pancreas
Epidemiology
Hospitalizations
Mortality
How to Cite
Abstract
INTRODUCTION: Pancreatic malignancy is a highly lethal cancer, characterized by the formation of aggressive tumors in the pancreatic tissue. Due to often late diagnosis and resistance to treatment, the disease has high mortality rates. This article will analyze the hospitalizations, deaths and mortality rates associated with this condition, highlighting the importance of early diagnosis and advanced therapeutic interventions. OBJECTIVE: This study aims to quantify and analyze the rates of hospitalizations, deaths and mortality rates due to malignant neoplasia of the pancreas in Brazil. METHODOLOGY: This is a retrospective study with a quantitative approach, carried out from data collection by the SUS Hospital Information System (SIH/SUS), made available by the secondary database of the Department of Informatics of the Unified Health System (TABNET /DATASUS). The data studied referred to hospitalizations, deaths and the mortality rate due to malignant neoplasia of the pancreas in Brazil in the period between April 2023 and April 2024. The analysis was carried out using descriptive statistics, tabulation in an electronic spreadsheet using the Microsoft Excel program 2016 arranged in tables using Microsoft Word 10. RESULTS: Data on malignant neoplasia of the pancreas in Brazil between April 2023 and April 2024 reveal a total of 19,291 hospitalizations and 3,834 deaths. The Southeast region had the highest number of both hospitalizations (8,599, 44.60%) and deaths (1,882, 49.13%), while the North region had the highest mortality rate (25.97 per 100,000 inhabitants). These numbers highlight the significant burden of this disease and the need for specific policies to reduce its impactful statistics. CONCLUSION: The data highlights the severity of pancreatic cancer in Brazil between April 2023 and April 2024, with a high incidence of hospitalizations and deaths, especially in the Southeast region. The North region faces the highest mortality rate, indicating an urgent need for improvements in access and treatment.
References
CARRERETTE, F. B.; SAITO, E. H.; RODRIGUES, L. S. Anais do 61º Congresso do Hospital Universitário Pedro Ernesto. Brazilian Journal of Health and Biomedical Sciences, v. 22, 16 ago. 2023.
COELHO, A. C. R. et al. Os principais desafios das políticas públicas de saúde para o enfrentamento das doenças crônicas não transmissíveis em municípios do Nordeste brasileiro. Cadernos Saúde Coletiva, v. 31, p. e31020095, 5 jun. 2023.
CONROY, T. et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Journal of Medicine, v. 364, n. 19, p. 1817–1825, 12 maio 2011.
DANTAS, M. N. P. et al. Fatores associados ao acesso precário aos serviços de saúde no Brasil. Revista Brasileira de Epidemiologia, v. 24, p. e210004, 18 dez. 2020.
INSTITUTO NACIONAL DE CÂNCER (INCA). Estatísticas de Câncer. Disponível em: https://www.inca.gov.br/numeros-de-cancer. Acesso em: 05 jul. 2024.
KANG, Y.-M. et al. Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment, v. 20, p. 15330338211043030, 7 out. 2021.
KLEIN, A. P. Identifying people at a high risk of developing pancreatic cancer. Nature Reviews. Cancer, v. 13, n. 1, p. 66–74, jan. 2013.
MACHADO, R. V. et al. PREVALÊNCIA DAS PRINCIPAIS DOENÇAS TRANSMISSÍVEIS E NÃO TRANSMISSÍVEIS QUE ACOMETEM A POPULAÇÃO RESIDENTE NA REGIÃO NORTE DO BRASIL E RELAÇÃO COM A NUTRIÇÃO. Anais do EVINCI - UniBrasil, v. 5, n. 1, p. 402–402, 2019.
MENDES, W. DE A. et al. Desenvolvimento humano e desigualdades regionais nos municípios brasileiros. Latin American Research Review, v. 55, n. 4, p. 742–758, dez. 2020.
RAPHAEL, B. et al. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, v. 32, p. 185-203.e13, 1 ago. 2017.
RIBEIRO, P. T. Perspectiva territorial, regionalização e redes: uma abordagem à política de saúde da República Federativa do Brasil. Saúde e Sociedade, v. 24, p. 403–412, jun. 2015.
RODRIGUES, E. T. Egressos de programas de residência em Medicina de Família e Comunidade do estado de São Paulo, 2000-2009. [s.l.] Universidade de São Paulo, 18 dez. 2012.
RYAN, D. P.; HONG, T. S.; BARDEESY, N. Pancreatic adenocarcinoma. The New England Journal of Medicine, v. 371, n. 11, p. 1039–1049, 11 set. 2014.
SANCIO, J. B. et al. Preoperative prognostic factors in patients with ductal adenocarcinoma of the head of the pancreas. Revista do Colégio Brasileiro de Cirurgiões, v. 47, p. e20202363, 3 jun. 2020.
SIEGEL, R. L.; MILLER, K. D.; JEMAL, A. Cancer statistics, 2020. CA: a cancer journal for clinicians, v. 70, n. 1, p. 7–30, jan. 2020.
SOUZA, M. D. G. G. D.; SANTOS, I. D.; SILVA, L. A. D. Educação em saúde e ações de autocuidado como determinantes para prevenção e controle do câncer. Revista de Pesquisa Cuidado é Fundamental Online, v. 7, n. 4, p. 3274–3291, 1 out. 2015.
WÖRMANN, S. M.; ALGÜL, H. Risk Factors and Therapeutic Targets in Pancreatic Cancer. Frontiers in Oncology, v. 3, p. 282, 18 nov. 2013.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Igor Gabriel Mendes Costa, Isabela Peres Martinho, Ana Luiza Matos Bezerra, Ricardo Trautwein Facci Segundo, Valéria Sampaio Travassos, Caio Feldberg Porto, Sofia Bezerra Sobral, Saymon Vitor Silva Corrêa, Alexandra Victoria Carapaica Mejias, Flaviane Lopes da Silva, Carlos César Freire Fróes, Érina Kenia Pires Gomes